Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

China Pharma Holdings (CPHI) Shares Outstanding (Weighted Average) (2016 - 2025)

China Pharma Holdings' Shares Outstanding (Weighted Average) history spans 16 years, with the latest figure at $4.3 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) rose 145.73% year-over-year to $4.3 million; the TTM value through Dec 2025 reached $4.3 million, up 145.73%, while the annual FY2025 figure was $4.3 million, 145.73% up from the prior year.
  • Shares Outstanding (Weighted Average) reached $4.3 million in Q4 2025 per CPHI's latest filing, up from $3.5 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $45.6 million in Q2 2021 to a low of $1.3 million in Q1 2024.
  • Average Shares Outstanding (Weighted Average) over 5 years is $5.6 million, with a median of $3.3 million recorded in 2025.
  • Peak YoY movement for Shares Outstanding (Weighted Average): tumbled 89.48% in 2022, then soared 145.73% in 2025.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $4.6 million in 2021, then rose by 3.91% to $4.8 million in 2022, then fell by 29.41% to $3.4 million in 2023, then crashed by 48.39% to $1.7 million in 2024, then skyrocketed by 145.73% to $4.3 million in 2025.
  • Per Business Quant, the three most recent readings for CPHI's Shares Outstanding (Weighted Average) are $4.3 million (Q4 2025), $3.5 million (Q3 2025), and $3.3 million (Q2 2025).